Saniona AB (CHIX:SANIOS) Non Operating Income: kr0.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:SANIOS Saniona AB CHIX:SANIOS
36 GF Score
Price kr12.94
! 3 Warning Signs
View Full Analysis

What is Saniona AB Non Operating Income?

Saniona AB CHIX:SANIOS 36 Non Operating Income is kr0.0 Mil as of Mar. 2026. GuruFocus rates CHIX:SANIOS with a GF Score™ of 36/100. The stock has 3 warning signs investors should review.

Non Operating Income is income or expense that comes from miscellaneous sources. Saniona AB's Non Operating Income for the three months ended in Mar. 2026 was kr0.0 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was kr0.0 Mil.

Saniona AB Non Operating Income Related Terms

Saniona AB Non Operating Income Historical Data

* Premium members only.

The historical data trend for Saniona AB's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Saniona AB Non Operating Income Chart

Saniona AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Non Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Saniona AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CHIX:SANIOS
36GF Score
Saniona AB CHIX:SANIOS
Non Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Saniona AB Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Non Operating Income →
What does a Non Operating Income of kr0.0 Mil mean?
Saniona AB (CHIX:SANIOS) has a Non Operating Income of kr0.0 Mil as of Mar. 2026. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Saniona AB and its competitors.
Is Saniona AB's Non Operating Income too high?
Saniona AB's current Non Operating Income is kr0.0 Mil. Overall, Saniona AB has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Saniona AB's Non Operating Income compare to VRTX and REGN?
Saniona AB's Non Operating Income of kr0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Non Operating Income for a Biotechnology company?
A good Non Operating Income depends on the Biotechnology industry context. However, Non Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Non Operating Income mean?
A high Non Operating Income can signal that a stock is expensive relative to its fundamentals. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Saniona AB and its competitors. Saniona AB's current Non Operating Income is kr0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saniona AB stock overvalued right now?
Saniona AB (CHIX:SANIOS) has a current Non Operating Income of kr0.0 Mil. The current Non Operating Income is kr0.0 Mil. Saniona AB's overall GF Score™ is 36/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Non Operating Income calculated?
Non Operating Income is calculated from a company's financial statements. For Saniona AB (CHIX:SANIOS), the current Non Operating Income is kr0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Saniona AB Business Description

Address Murervangen 42, Glostrup, DNK, DK-2600
Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases, and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, SAN903, and SAN2219. Geographically, it operates in USA, Sweden, Germany, Denmark, and United Kingdom, out of which it derives maximum revenue from USA.
36GF Score

Get the complete analysis for CHIX:SANIOS

Non Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr12.94
Price